Population Health and Disparities
Our work in Population Health and Disparities
-
Cross-Sectional Study Examining Household Factors Associated with SARS-CoV-2 Seropositivity in Low-Income Children in L.A.
Food insecure households with low head-of-household education, and at least one household member with type 2 diabetes, had the highest risk of SARS-CoV-2.
Categorized in -
Assessment of Medical and Public Assistance Expenditures and Employment Among US Adults With Cancer Diagnoses
History of cancer was associated with increased likelihood of disability, higher medical spending, and decreased likelihood of employment.
Categorized in -
Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US
This cross-sectional study analyzed data from a telehealth OUD treatment provider group currently operating in 32 states to assess the extent of buprenorphine availability at local pharmacies.
Categorized in -
Investigating the Complexity of Naloxone Distribution: Which Policies Matter for Pharmacies and Potential Recipients
Despite efforts to address the opioid crisis, opioid-related overdoses remain a significant contributor to mortality.
Categorized in -
Alternatives to the QALY for Comparative Effectiveness Research
We now have useful and valid alternatives that allow for the assessment and valuation of treatments that improve population health without discriminating against vulnerable patient populations.
Categorized in -
Projected Health Benefits and Health Care Savings from the United States National Hepatitis C Elimination Initiative
The national hepatitis C elimination initiative would substantially reduce HCV-related morbidity and mortality and would reduce healthcare spending at 10 years and beyond.
Categorized in -
The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Measuring the Value of Gains in Health: An Exact Formulation
Abstract The generalized risk-adjusted cost-effectiveness (GRACE) model generalizes conventional cost-effectiveness analysis (CEA) by introducing diminishing returns to Health-Related Quality of Life (QoL). This changes CEA practice in three ways: (1) Willingness to pay (WTP) increases exponentially with untreated illness severity or pre-existing permanent disability, and WTP ends up lower for mild diseases but higher for […]
Categorized in -
Shuttered Pharmacies: A Major Hole in Healthcare
Pharmacy deserts contribute to persistent racial and ethnic health disparities. Why is this happening and what can be done to ensure access to pharmacy services?
-
Methods to Adjust Willingness to Pay (WTP) Measures for Severity of Illness
Abstract Objectives Both private sector organizations and governmental health agencies increasingly use illness severity measures to adjust willingness-to-pay thresholds. Three widely discussed methods—absolute shortfall (AS), proportional shortfall (PS), and fair innings (FI)—all use ad hoc adjustments to cost-effectiveness analysis methods and “stair-step” brackets to link illness severity with willingness-to-pay adjustments. We assess how these methods […]
Categorized in -
American Life in Realtime: a Benchmark Registry of Health Data for Equitable Precision Health
Applying artificial intelligence and machine learning to person-generated health data allows unprecedented assessment of associations between everyday life and health outcomes.
Categorized in